XML 30 R22.htm IDEA: XBRL DOCUMENT v3.24.2
Investments in and Advances to Joint Ventures (Tables)
6 Months Ended
Jun. 30, 2024
Schedule of Equity Method Investments [Line Items]  
Schedule of Changes to Investments in and Advances to Joint Ventures The changes to Investments in and Advances to Joint Ventures are as follows (in thousands):

Balance, December 31, 2023

$

39,372

 

Equity in net loss

 

(1,223

)

Distributions

 

(800

)

Contributions

 

916

 

Amortization of basis differentials

 

1,424

 

Carrying value of previously held equity interest

 

(6,146

)

Repayment of advances

 

(730

)

Change in fair value of derivative

 

(237

)

Balance, June 30, 2024

$

32,576

 

Schedule of Reconciliation of Consolidated Joint Venture Equity

A reconciliation of the consolidated joint venture equity is as follows (in thousands):

 

June 30, 2024

 

 

December 31, 2023

 

Company's share of accumulated equity

$

28,220

 

 

$

35,782

 

Basis differentials

 

2,329

 

 

 

1,099

 

Deferred leasing and development fees, net of portion related to the Company's interest

 

 

 

 

(136

)

Amounts payable to the Company

 

2,027

 

 

 

2,627

 

Investments in and Advances to Joint Ventures, net

$

32,576

 

 

$

39,372